RXST insider transaction filings

RxSight, Inc. — 34 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-24. Screen RXST transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-244Mottiwala Aziz — President and CEO, DirectorGrant/award (A): 2,312,138 (derivative) @ $0 · Grant/award (A): 571,286 (derivative) @ $0EDGAR
2026-06-184Warner Robert Keith — DirectorGrant/award (A): 37,037EDGAR
2026-06-184PALMISANO ROBERT J — DirectorGrant/award (A): 37,037EDGAR
2026-06-184Maniar Shweta — DirectorGrant/award (A): 37,037EDGAR
2026-06-184Fountain Tamara — DirectorGrant/award (A): 37,037EDGAR
2026-06-184LINK WILLIAM J PHD — DirectorGrant/award (A): 37,037EDGAR
2026-06-184Corley Jesse Anderson — DirectorGrant/award (A): 37,037EDGAR
2026-06-184COHEN RAYMOND W — DirectorGrant/award (A): 30,864EDGAR
2026-06-184Tammenoms Bakker Juliet — DirectorGrant/award (A): 37,037EDGAR
2026-06-184Andrews Julie — DirectorGrant/award (A): 37,037EDGAR
2026-04-204Goldshleger Ilya — Chief Operating OfficerOption exercise (M): 12,489 @ $4.13 · Option exercise (M): 12,489 (derivative) @ $0EDGAR
2026-03-034Wilterding Mark — Chief Financial OfficerOption exercise (M): 20,441 · Tax withholding (F): 8,068 @ $7.61 · Option exercise (M): 20,441 (derivative) @ $0EDGAR
2026-03-034Gaines Scott — Chief Customer OfficerOption exercise (M): 6,261 · Tax withholding (F): 2,580 @ $7.61 · Grant/award (A): 32,218 (derivative) @ $0 · Option exercise (M): 1,500 (derivative) @ $0 · Option exercise (M): 604 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 · +2 moreEDGAR
2026-03-034Goldshleger Ilya — Chief Operating OfficerGrant/award (A): 32,218 (derivative) @ $0EDGAR
2026-03-034Weinberg Eric — See remarksGrant/award (A): 32,218 (derivative) @ $0EDGAR
2026-03-034Kurtz Ronald M MD — President & CEO, DirectorGrant/award (A): 80,545 (derivative) @ $0EDGAR
2026-01-304Wilterding Mark — Chief Financial OfficerGrant/award (A): 258,770 (derivative) @ $0 · Grant/award (A): 163,528 (derivative) @ $0EDGAR
2025-09-264Goldshleger Ilya — See remarksOption exercise (M): 15,096 @ $4.34 · Option exercise (M): 8,349 @ $4.13 · Option exercise (M): 5,416 (derivative) @ $0 · Option exercise (M): 9,680 (derivative) @ $0 · Option exercise (M): 8,349 (derivative) @ $0EDGAR
2025-08-044COHEN RAYMOND W — DirectorGrant/award (A): 35,668 @ $0EDGAR
2025-06-044LINK WILLIAM J PHD — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Fountain Tamara — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Warner Robert Keith — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Maniar Shweta — DirectorGrant/award (A): 10,752EDGAR
2025-06-044PALMISANO ROBERT J — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Andrews Julie — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Tammenoms Bakker Juliet — DirectorGrant/award (A): 10,752EDGAR
2025-06-044Corley Jesse Anderson — DirectorGrant/award (A): 10,752EDGAR
2025-06-034Weinberg Eric — See remarksOption exercise (M): 188,002 @ $3.93 · Option exercise (M): 188,002 (derivative) @ $0EDGAR
2025-04-154Thunen Shelley B — See remarksOption exercise (M): 7,792 @ $4.34 · Option exercise (M): 6,405 (derivative) @ $0 · Option exercise (M): 1,387 (derivative) @ $0EDGAR
2025-03-134Fountain Tamara — DirectorSale (S): 7,000 @ $25.71EDGAR
2025-02-274Weinberg Eric — See remarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-02-274Goldshleger Ilya — See remarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-02-274Thunen Shelley B — See remarksGrant/award (A): 125,000 (derivative) @ $0EDGAR
2025-02-274Kurtz Ronald M MD — President & CEO, DirectorGrant/award (A): 215,000 (derivative) @ $0EDGAR

Recent 8-K events — RxSight, Inc.

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-068-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-02-258-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RXST returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →